Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study - Concepedia

Concepedia

Publication | Open Access

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study

DOI Full Paper Access

37

Citations

28

References

2017

Year

Uri Kopylov, Konstantinos Papamichael, Matti Waterman, Ariella Bar‐Gil Shitrit, Trine Boysen, Francisco Portela, Armando Peixoto, Andrew Szilagyi, Marco Silva, Giovanni Maconi,

Inflammatory Bowel Diseases

Abstract

IFX or cyclosporine therapy is not associated with additional risk for colectomy over antiviral therapy alone in hospitalized CMV-positive patients with UC.

References

	Year	Citations

Page 1